Science 19 March 1993: Vol. 259. no. 5102, pp. 1745 - 1749 DOI: 10.1126/science.8456302

Prev | Table of Contents | Next

Articles

Analysis of Modified Human Papillomavirus Type 16 L1 Capsomeres: the Ability To Assemble into Larger Particles Correlates with Higher Immunogenicity.

L. Schadlich, T. Senger, B. Gerlach, N. Mucke, C. Klein, I. G. Bravo, M. Muller, and L. Gissmann (2009)
J. Virol. 83, 7690-7705
 |  Abstract »  |  Full Text »  |  PDF »

Immune effects against influenza A virus and a novel DNA vaccine with co-expression of haemagglutinin- and neuraminidase-encoding genes.

W. Zhang, W. Li, Y. Li, H. Li, B. Wang, F. Wang, Y. Zhu, Z. Jiang, L. Zhong, and M. Li (2009)
J. Med. Microbiol. 58, 845-854
 |  Abstract »  |  Full Text »  |  PDF »

Generation of High-Titer Neutralizing Antibodies against Botulinum Toxins A, B, and E by DNA Electrotransfer.

C. Trollet, Y. Pereira, A. Burgain, E. Litzler, M. Mezrahi, J. Seguin, M. Manich, M. R. Popoff, D. Scherman, and P. Bigey (2009)
Infect. Immun. 77, 2221-2229
 |  Abstract »  |  Full Text »  |  PDF »

A humanized anti-M2 scFv shows protective in vitro activity against influenza.

J. Gabbard, N. Velappan, R. Di Niro, J. Schmidt, C.A. Jones, S.M. Tompkins, and A.R.M. Bradbury (2009)
Protein Eng. Des. Sel. 22, 189-198
 |  Abstract »  |  Full Text »  |  PDF »

A Novel Role for Non-Neutralizing Antibodies against Nucleoprotein in Facilitating Resistance to Influenza Virus.

D. M. Carragher, D. A. Kaminski, A. Moquin, L. Hartson, and T. D. Randall (2008)
J. Immunol. 181, 4168-4176
 |  Abstract »  |  Full Text »  |  PDF »

Characterization of T-cell immunogenicity of two PE/PPE proteins of Mycobacterium tuberculosis.

M. G. Chaitra, M. S. Shaila, and R. Nayak (2008)
J. Med. Microbiol. 57, 1079-1086
 |  Abstract »  |  Full Text »  |  PDF »

Synergistic tumoricidal effect of combined hMUC1 vaccination and hNIS radioiodine gene therapy.

Y. H. Jeon, Y. Choi, S. O. Yoon, C. W. Kim, and J.-K. Chung (2008)
Mol. Cancer Ther. 7, 2252-2260
 |  Abstract »  |  Full Text »  |  PDF »

Hydrophobic Inactivation of Influenza Viruses Confers Preservation of Viral Structure with Enhanced Immunogenicity.

Y. Raviv, R. Blumenthal, S. M. Tompkins, J. Humberd, R. J. Hogan, and M. Viard (2008)
J. Virol. 82, 4612-4619
 |  Abstract »  |  Full Text »  |  PDF »

Parenteral immunization of mice with a genetically inactivated pertussis toxin DNA vaccine induces cell-mediated immunity and protection.

S. R. Fry, A. Y. Chen, G. Daggard, and T. K. S. Mukkur (2008)
J. Med. Microbiol. 57, 28-35
 |  Abstract »  |  Full Text »  |  PDF »

B Cells Promote Resistance to Heterosubtypic Strains of Influenza via Multiple Mechanisms.

J. Rangel-Moreno, D. M. Carragher, R. S. Misra, K. Kusser, L. Hartson, A. Moquin, F. E. Lund, and T. D. Randall (2008)
J. Immunol. 180, 454-463
 |  Abstract »  |  Full Text »  |  PDF »

Rectification of Age-Associated Deficiency in Cytotoxic T Cell Response to Influenza A Virus by Immunization with Immune Complexes.

B. Zheng, Y. Zhang, H. He, E. Marinova, K. Switzer, D. Wansley, I. Mbawuike, and S. Han (2007)
J. Immunol. 179, 6153-6159
 |  Abstract »  |  Full Text »  |  PDF »

Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus.

M. Kwissa, R. R. Amara, H. L. Robinson, B. Moss, S. Alkan, A. Jabbar, F. Villinger, and B. Pulendran (2007)
J. Exp. Med. 204, 2733-2746
 |  Abstract »  |  Full Text »  |  PDF »

Genetic Alteration of Mycobacterium smegmatis To Improve Mycobacterium-Mediated Transfer of Plasmid DNA into Mammalian Cells and DNA Immunization.

Y. Mo, N. M. Quanquin, W. H. Vecino, U. D. Ranganathan, L. Tesfa, W. Bourn, K. M. Derbyshire, N. L. Letvin, W. R. Jacobs Jr., and G. J. Fennelly (2007)
Infect. Immun. 75, 4804-4816
 |  Abstract »  |  Full Text »  |  PDF »

Potential of Transfected Muscle Cells to Contribute to DNA Vaccine Immunogenicity.

H. Shirota, L. Petrenko, C. Hong, and D. M. Klinman (2007)
J. Immunol. 179, 329-336
 |  Abstract »  |  Full Text »  |  PDF »

Effect of Plasmid DNA Vaccine Design and In Vivo Electroporation on the Resulting Vaccine-Specific Immune Responses in Rhesus Macaques.

A. Luckay, M. K. Sidhu, R. Kjeken, S. Megati, S.-Y. Chong, V. Roopchand, D. Garcia-Hand, R. Abdullah, R. Braun, D. C. Montefiori, et al. (2007)
J. Virol. 81, 5257-5269
 |  Abstract »  |  Full Text »  |  PDF »

Human Metapneumovirus Fusion Protein Vaccines That Are Immunogenic and Protective in Cotton Rats.

G. Cseke, D. W. Wright, S. J. Tollefson, J. E. Johnson, J. E. Crowe Jr., and J. V. Williams (2007)
J. Virol. 81, 698-707
 |  Abstract »  |  Full Text »  |  PDF »

Bicistronic Woodchuck Hepatitis Virus Core and Gamma Interferon DNA Vaccine Can Protect from Hepatitis but Does Not Elicit Sterilizing Antiviral Immunity.

J. Wang, S. A. Gujar, L. Cova, and T. I. Michalak (2007)
J. Virol. 81, 903-916
 |  Abstract »  |  Full Text »  |  PDF »

Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle..

R. Liang, J. V. van den Hurk, L. A. Babiuk, and S. van Drunen Littel-van den Hurk (2006)
J. Gen. Virol. 87, 2971-2982
 |  Abstract »  |  Full Text »  |  PDF »

Topical Application of Escherichia coli-Vectored Vaccine as a Simple Method for Eliciting Protective Immunity..

J. Zhang, Z. Shi, F.-k. Kong, E. Jex, Z. Huang, J. M. Watt, K. R. Van Kampen, and D.-c. C. Tang (2006)
Infect. Immun. 74, 3607-3617
 |  Abstract »  |  Full Text »  |  PDF »

Mutations in Influenza Virus M1 CCHH, the Putative Zinc Finger Motif, Cause Attenuation in Mice and Protect Mice against Lethal Influenza Virus Infection..

E. K.-W. Hui, D. F. Smee, M.-H. Wong, and D. P. Nayak (2006)
J. Virol. 80, 5697-5707
 |  Abstract »  |  Full Text »  |  PDF »

Insufficient APC Capacities of Dendritic Cells in Gene Gun-Mediated DNA Vaccination..

H. Lauterbach, A. Gruber, C. Ried, C. Cheminay, and T. Brocker (2006)
J. Immunol. 176, 4600-4607
 |  Abstract »  |  Full Text »  |  PDF »

Boosting Immune Response to Hepatitis B DNA Vaccine by Coadministration of Prothymosin {alpha}-Expressing Plasmid.

Y. Jin, C. Cao, P. Li, X. Liu, W. Huang, C. Li, and Q. Ma (2005)
Clin. Vaccine Immunol. 12, 1364-1369
 |  Abstract »  |  Full Text »  |  PDF »

PROTECTION AGAINST SCRUB TYPHUS BY A PLASMID VACCINE ENCODING THE 56-KD OUTER MEMBRANE PROTEIN ANTIGEN GENE.

Y.-S. NI, T.-C. CHAN, C.-C. CHAO, A. L. RICHARDS, G. A. DASCH, and W.-M. CHING (2005)
Am J Trop Med Hyg 73, 936-941
 |  Abstract »  |  Full Text »  |  PDF »

Activation of Innate Immunity, Inflammation, and Potentiation of DNA Vaccination through Mammalian Expression of the TLR5 Agonist Flagellin.

S. E. Applequist, E. Rollman, M. D. Wareing, M. Liden, B. Rozell, J. Hinkula, and H.-G. Ljunggren (2005)
J. Immunol. 175, 3882-3891
 |  Abstract »  |  Full Text »  |  PDF »

Molecular Biology of Pseudorabies Virus: Impact on Neurovirology and Veterinary Medicine.

L. E. Pomeranz, A. E. Reynolds, and C. J. Hengartner (2005)
Microbiol. Mol. Biol. Rev. 69, 462-500
 |  Abstract »  |  Full Text »  |  PDF »

Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors.

C. Coban, K. J. Ishii, M. Gursel, D. M. Klinman, and N. Kumar (2005)
J. Leukoc. Biol. 78, 647-655
 |  Abstract »  |  Full Text »  |  PDF »

A Human T-Cell Leukemia Virus Type 1 Regulatory Element Enhances the Immunogenicity of Human Immunodeficiency Virus Type 1 DNA Vaccines in Mice and Nonhuman Primates.

D. H. Barouch, Z.-y. Yang, W.-p. Kong, B. Korioth-Schmitz, S. M. Sumida, D. M. Truitt, M. G. Kishko, J. C. Arthur, A. Miura, J. R. Mascola, et al. (2005)
J. Virol. 79, 8828-8834
 |  Abstract »  |  Full Text »  |  PDF »

DNA Vaccines: Progress and Challenges.

J. J. Donnelly, B. Wahren, and M. A. Liu (2005)
J. Immunol. 175, 633-639
 |  Abstract »  |  Full Text »  |  PDF »

DNA Vaccines Expressing Different Forms of Simian Immunodeficiency Virus Antigens Decrease Viremia upon SIVmac251 Challenge.

M. Rosati, A. von Gegerfelt, P. Roth, C. Alicea, A. Valentin, M. Robert-Guroff, D. Venzon, D. C. Montefiori, P. Markham, B. K. Felber, et al. (2005)
J. Virol. 79, 8480-8492
 |  Abstract »  |  Full Text »  |  PDF »

Electroporation as a "Prime/Boost" Strategy for Naked DNA Vaccination against a Tumor Antigen.

S. Buchan, E. Gronevik, I. Mathiesen, C. A. King, F. K. Stevenson, and J. Rice (2005)
J. Immunol. 174, 6292-6298
 |  Abstract »  |  Full Text »  |  PDF »

Boosting of DNA Vaccine-Elicited Gamma Interferon Responses in Humans by Exposure to Malaria Parasites.

R. Wang, T. L. Richie, M. F. Baraceros, N. Rahardjo, T. Gay, J.-G. Banania, Y. Charoenvit, J. E. Epstein, T. Luke, D. A. Freilich, et al. (2005)
Infect. Immun. 73, 2863-2872
 |  Abstract »  |  Full Text »  |  PDF »

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.

D. P. Webster, S. Dunachie, J. M. Vuola, T. Berthoud, S. Keating, S. M. Laidlaw, S. J. McConkey, I. Poulton, L. Andrews, R. F. Andersen, et al. (2005)
PNAS 102, 4836-4841
 |  Abstract »  |  Full Text »  |  PDF »

Neutralizing Antibodies Elicited by Immunization of Monkeys with DNA Plasmids and Recombinant Adenoviral Vectors Expressing Human Immunodeficiency Virus Type 1 Proteins.

J. R. Mascola, A. Sambor, K. Beaudry, S. Santra, B. Welcher, M. K. Louder, T. C. VanCott, Y. Huang, B. K. Chakrabarti, W.-P. Kong, et al. (2005)
J. Virol. 79, 771-779
 |  Abstract »  |  Full Text »  |  PDF »

Gene Vaccination to Bias the Immune Response to Amyloid-{beta} Peptide as Therapy for Alzheimer Disease.

B. Qu, R. N. Rosenberg, L. Li, P. J. Boyer, and S. A. Johnston (2004)
Arch Neurol 61, 1859-1864
 |  Abstract »  |  Full Text »  |  PDF »

Protective Efficacy of a DNA Influenza Virus Vaccine Is Markedly Increased by the Coadministration of a Schiff Base-Forming Drug.

J. Charo, J. A. Lindencrona, L.-M. Carlson, J. Hinkula, and R. Kiessling (2004)
J. Virol. 78, 11321-11326
 |  Abstract »  |  Full Text »  |  PDF »

Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3.

H. Yu, L. A. Babiuk, and S. van Drunen Littel-van den Hurk (2004)
J. Gen. Virol. 85, 1533-1543
 |  Abstract »  |  Full Text »  |  PDF »

DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade.

M. Giri, K. E. Ugen, and D. B. Weiner (2004)
Clin. Microbiol. Rev. 17, 370-389
 |  Abstract »  |  Full Text »  |  PDF »

Intraspleen Delivery of a DNA Vaccine Coding for Superoxide Dismutase (SOD) of Brucella abortus Induces SOD-Specific CD4+ and CD8+ T Cells.

C. Munoz-Montesino, E. Andrews, R. Rivers, A. Gonzalez-Smith, G. Moraga-Cid, H. Folch, S. Cespedes, and A. A. Onate (2004)
Infect. Immun. 72, 2081-2087
 |  Abstract »  |  Full Text »  |  PDF »

Persistency of Adenoviral-Mediated Lysostaphin Expression in Goat Mammary Glands.

W. Fan, K. Plaut, A. J. Bramley, J. W. Barlow, S. A. Mischler, and D. E. Kerr (2004)
J Dairy Sci 87, 602-608
 |  Abstract »  |  Full Text »  |  PDF »

Recognition of Homo- and Heterosubtypic Variants of Influenza A Viruses by Human CD8+ T Lymphocytes.

A. C. M. Boon, G. de Mutsert, D. van Baarle, D. J. Smith, A. S. Lapedes, R. A. M. Fouchier, K. Sintnicolaas, A. D. M. E. Osterhaus, and G. F. Rimmelzwaan (2004)
J. Immunol. 172, 2453-2460
 |  Abstract »  |  Full Text »  |  PDF »

Systemic Administration of IL-18 Promotes Diabetes Development in Young Nonobese Diabetic Mice.

Y. Oikawa, A. Shimada, A. Kasuga, J. Morimoto, T. Osaki, H. Tahara, T. Miyazaki, F. Tashiro, E. Yamato, J.-i. Miyazaki, et al. (2003)
J. Immunol. 171, 5865-5875
 |  Abstract »  |  Full Text »  |  PDF »

A DNA Vaccine Encoding Cu,Zn Superoxide Dismutase of Brucella abortus Induces Protective Immunity in BALB/c Mice.

A. A. Onate, S. Cespedes, A. Cabrera, R. Rivers, A. Gonzalez, C. Munoz, H. Folch, and E. Andrews (2003)
Infect. Immun. 71, 4857-4861
 |  Abstract »  |  Full Text »  |  PDF »

Prime-Boost Vaccination with HIV-1 Gag Protein and Cytosine Phosphate Guanosine Oligodeoxynucleotide, Followed by Adenovirus, Induces Sustained and Robust Humoral and Cellular Immune Responses.

M. Tritel, A. M. Stoddard, B. J. Flynn, P. A. Darrah, C.-y. Wu, U. Wille, J. A. Shah, Y. Huang, L. Xu, M. R. Betts, et al. (2003)
J. Immunol. 171, 2538-2547
 |  Abstract »  |  Full Text »  |  PDF »

Induction of Broad and Potent Anti-Human Immunodeficiency Virus Immune Responses in Rhesus Macaques by Priming with a DNA Vaccine and Boosting with Protein-Adsorbed Polylactide Coglycolide Microparticles.

G. Otten, M. Schaefer, C. Greer, M. Calderon-Cacia, D. Coit, J. Kazzaz, A. Medina-Selby, M. Selby, M. Singh, M. Ugozzoli, et al. (2003)
J. Virol. 77, 6087-6092
 |  Abstract »  |  Full Text »  |  PDF »

On the Use of DNA Vaccines for the Prophylaxis of Mycobacterial Diseases.

K. Huygen (2003)
Infect. Immun. 71, 1613-1621
 |  Full Text »

Optimization of DNA-based Vaccination in Cows Using Green Fluorescent Protein and Protein A as a Prelude to Immunization Against Staphylococcal Mastitis.

E. W. Carter and D. E. Kerr (2003)
J Dairy Sci 86, 1177-1186
 |  Abstract »  |  Full Text »  |  PDF »

Gene Vaccines.

I. K. Srivastava and M. A. Liu (2003)
Ann Intern Med 138, 550-559
 |  Abstract »  |  Full Text »  |  PDF »

Effective Protective Immunity to Yersinia pestis Infection Conferred by DNA Vaccine Coding for Derivatives of the F1 Capsular Antigen.

H. Grosfeld, S. Cohen, T. Bino, Y. Flashner, R. Ber, E. Mamroud, C. Kronman, A. Shafferman, and B. Velan (2003)
Infect. Immun. 71, 374-383
 |  Abstract »  |  Full Text »  |  PDF »

DNA Immunization with Hepatitis C Virus (HCV) Polycistronic Genes or Immunization by HCV DNA Priming-Recombinant Canarypox Virus Boosting Induces Immune Responses and Protection from Recombinant HCV-Vaccinia Virus Infection in HLA-A2.1-Transgenic Mice.

P. Pancholi, M. Perkus, N. Tricoche, Q. Liu, and A. M. Prince (2002)
J. Virol. 77, 382-390
 |  Abstract »  |  Full Text »  |  PDF »

Marked Enhancement of the Antigen-Specific Immune Response by Combining Plasmid DNA-Based Immunization with a Schiff Base-Forming Drug.

J. Charo, M. Sundback, K. Wasserman, A.-M. T. Ciupitu, B. Mirzai, R. van der Zee, and R. Kiessling (2002)
Infect. Immun. 70, 6652-6657
 |  Abstract »  |  Full Text »  |  PDF »

Efficient Priming of CD4+ and CD8+ T Cells by DNA Vaccination Depends on Appropriate Targeting of Sufficient Levels of Immunologically Relevant Antigen to Appropriate Processing Pathways.

C. Rush, T. Mitchell, and P. Garside (2002)
J. Immunol. 169, 4951-4960
 |  Abstract »  |  Full Text »  |  PDF »

Vaccination with Minigenes Encoding VH-derived Major Histocompatibility Complex Class I-binding Epitopes Activates Cytotoxic T Cells that Ablate Autoantibody-producing B Cells and Inhibit Lupus.

G.-C. Fan and R. R. Singh (2002)
J. Exp. Med. 196, 731-741
 |  Abstract »  |  Full Text »  |  PDF »

Structural Elements of a Protein Antigen Determine Immunogenicity of the Embedded MHC Class I-Restricted T Cell Epitope.

W. Paster, M. Kalat, M. Zehetner, and T. Schweighoffer (2002)
J. Immunol. 169, 2937-2946
 |  Abstract »  |  Full Text »  |  PDF »

Safety and Immunogenicity of a DNA Vaccine Encoding Carcinoembryonic Antigen and Hepatitis B Surface Antigen in Colorectal Carcinoma Patients.

R. M. Conry, D. T. Curiel, T. V. Strong, S. E. Moore, K. O. Allen, D. L. Barlow, D. R. Shaw, and A. F. LoBuglio (2002)
Clin. Cancer Res. 8, 2782-2787
 |  Abstract »  |  Full Text »  |  PDF »

A DNA Vaccine Encoding Lumazine Synthase from Brucella abortus Induces Protective Immunity in BALB/c Mice.

C. A. Velikovsky, J. Cassataro, G. H. Giambartolomei, F. A. Goldbaum, S. Estein, R. A. Bowden, L. Bruno, C. A. Fossati, and M. Spitz (2002)
Infect. Immun. 70, 2507-2511
 |  Abstract »  |  Full Text »  |  PDF »

The Potential of DNA Vaccination against Tumor-Associated Antigens for Antitumor Therapy.

K. Haupt, M. Roggendorf, and K. Mann (2002)
Experimental Biology and Medicine 227, 227-237
 |  Abstract »  |  Full Text »  |  PDF »

Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunisation with herpes simplex virus type-1 genes specifying glycoproteins gB and gD.

A. BAGHIAN, V. N. CHOULJENKO, O. D'AUVERGNE, M. J. NEWMAN, S. BAGHIAN, and K. G. KOUSOULAS (2002)
J. Med. Microbiol. 51, 350-357
 |  Abstract »  |  Full Text »  |  PDF »

Induction of Long-Term Memory CD8+ T Cells for Recall of Viral Clearing Responses against Influenza Virus.

G. Deliyannis, D. C. Jackson, N. J. Ede, W. Zeng, I. Hourdakis, E. Sakabetis, and L. E. Brown (2002)
J. Virol. 76, 4212-4221
 |  Abstract »  |  Full Text »  |  PDF »

Induction of Mucosal Protection against Primary, Heterologous Simian Immunodeficiency Virus by a DNA Vaccine.

D. H. Fuller, P. A. Rajakumar, L. A. Wilson, A. M. Trichel, J. T. Fuller, T. Shipley, M. S. Wu, K. Weis, C. R. Rinaldo, J. R. Haynes, et al. (2002)
J. Virol. 76, 3309-3317
 |  Abstract »  |  Full Text »  |  PDF »

The Magnitude and Specificity of Influenza A Virus-Specific Cytotoxic T-Lymphocyte Responses in Humans Is Related to HLA-A and -B Phenotype.

A. C. M. Boon, G. de Mutsert, Y. M. F. Graus, R. A. M. Fouchier, K. Sintnicolaas, A. D. M. E. Osterhaus, and G. F. Rimmelzwaan (2002)
J. Virol. 76, 582-590
 |  Abstract »  |  Full Text »  |  PDF »

Potent CD4+ T Cell Responses Elicited by a Bicistronic HIV-1 DNA Vaccine Expressing gp120 and GM-CSF.

D. H. Barouch, S. Santra, K. Tenner-Racz, P. Racz, M. J. Kuroda, J. E. Schmitz, S. S. Jackson, M. A. Lifton, D. C. Freed, H. C. Perry, et al. (2002)
J. Immunol. 168, 562-568
 |  Abstract »  |  Full Text »  |  PDF »

Effects of Antigen and Genetic Adjuvants on Immune Responses to Human Immunodeficiency Virus DNA Vaccines in Mice.

A. C. Moore, W.-p. Kong, B. K. Chakrabarti, and G. J. Nabel (2002)
J. Virol. 76, 243-250
 |  Abstract »  |  Full Text »  |  PDF »

Protection against Tetanus by Needle-Free Inoculation of Adenovirus-Vectored Nasal and Epicutaneous Vaccines.

Z. Shi, M. Zeng, G. Yang, F. Siegel, L. J. Cain, K. R. van Kampen, C. A. Elmets, and D.-C. C. Tang (2001)
J. Virol. 75, 11474-11482
 |  Abstract »  |  Full Text »

Multiple Effects of Codon Usage Optimization on Expression and Immunogenicity of DNA Candidate Vaccines Encoding the Human Immunodeficiency Virus Type 1 Gag Protein.

L. Deml, A. Bojak, S. Steck, M. Graf, J. Wild, R. Schirmbeck, H. Wolf, and R. Wagner (2001)
J. Virol. 75, 10991-11001
 |  Abstract »  |  Full Text »  |  PDF »

CD4+ T Cells Induced by a DNA Vaccine: Immunological Consequences of Epitope-Specific Lysosomal Targeting.

F. Rodriguez, S. Harkins, J. M. Redwine, J. M. de Pereda, and J. L. Whitton (2001)
J. Virol. 75, 10421-10430
 |  Abstract »  |  Full Text »  |  PDF »

Transplacental Genetic Immunization After Intravenous Delivery of Plasmid DNA to Pregnant Mice.

K. Okuda, K.-Q. Xin, A. Haruki, S. Kawamoto, Y. Kojima, F. Hirahara, H. Okada, D. Klinman, and K. Hamajima (2001)
J. Immunol. 167, 5478-5484
 |  Abstract »  |  Full Text »  |  PDF »

Induction of Immune Response in BALB/c Mice with a DNA Vaccine Encoding Bacterioferritin or P39 of Brucella spp..

A. Al-Mariri, A. Tibor, P. Mertens, X. De Bolle, P. Michel, J. Godfroid, K. Walravens, and J.-J. Letesson (2001)
Infect. Immun. 69, 6264-6270
 |  Abstract »  |  Full Text »  |  PDF »

Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA Vaccines.

D. O'Hagan, M. Singh, M. Ugozzoli, C. Wild, S. Barnett, M. Chen, M. Schaefer, B. Doe, G. R. Otten, and J. B. Ulmer (2001)
J. Virol. 75, 9037-9043
 |  Abstract »  |  Full Text »  |  PDF »

Genetic Immunization with the Region Encoding the {alpha}-Helical Domain of PspA Elicits Protective Immunity against Streptococcus pneumoniae.

J. R. Bosarge, J. M. Watt, D. O. McDaniel, E. Swiatlo, and L. S. McDaniel (2001)
Infect. Immun. 69, 5456-5463
 |  Abstract »  |  Full Text »  |  PDF »

Two Overlapping Subdominant Epitopes Identified by DNA Immunization Induce Protective CD8+ T-Cell Populations with Differing Cytolytic Activities.

F. Rodriguez, M. K. Slifka, S. Harkins, and J. L. Whitton (2001)
J. Virol. 75, 7399-7409
 |  Abstract »  |  Full Text »  |  PDF »

Dendritic Cells Can Initiate Protective Immune Responses against Malaria.

O. Bruna-Romero and A. Rodriguez (2001)
Infect. Immun. 69, 5173-5176
 |  Abstract »  |  Full Text »  |  PDF »

Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein.

M. Vignuzzi, S. Gerbaud, S. van der Werf, and N. Escriou (2001)
J. Gen. Virol. 82, 1737-1747
 |  Abstract »  |  Full Text »  |  PDF »

Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection.

T. M. Tumpey, M. Renshaw, J. D. Clements, and J. M. Katz (2001)
J. Virol. 75, 5141-5150
 |  Abstract »  |  Full Text »

Arg-Gingipain A DNA Vaccine Induces Protective Immunity against Infection by Porphyromonas gingivalis in a Murine Model.

H. Yonezawa, K. Ishihara, and K. Okuda (2001)
Infect. Immun. 69, 2858-2864
 |  Abstract »  |  Full Text »  |  PDF »

Defined Flanking Spacers and Enhanced Proteolysis Is Essential for Eradication of Established Tumors by an Epitope String DNA Vaccine.

M. P. Velders, S. Weijzen, G. L. Eiben, A. G. Elmishad, P.-M. Kloetzel, T. Higgins, R. B. Ciccarelli, M. Evans, S. Man, L. Smith, et al. (2001)
J. Immunol. 166, 5366-5373
 |  Abstract »  |  Full Text »  |  PDF »

The Potency and Durability of DNA- and Protein-Based Vaccines Against Leishmania major Evaluated Using Low-Dose, Intradermal Challenge.

S. Mendez, S. Gurunathan, S. Kamhawi, Y. Belkaid, M. A. Moga, Y. A. W. Skeiky, A. Campos-Neto, S. Reed, R. A. Seder, and D. Sacks (2001)
J. Immunol. 166, 5122-5128
 |  Abstract »  |  Full Text »  |  PDF »

Vaccination Strategies for Mucosal Immune Responses.

P. L. Ogra, H. Faden, and R. C. Welliver (2001)
Clin. Microbiol. Rev. 14, 430-445
 |  Abstract »  |  Full Text »  |  PDF »

Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine.

N. K. Polakos, D. Drane, J. Cox, P. Ng, M. J. Selby, D. Chien, D. T. O'Hagan, M. Houghton, and X. Paliard (2001)
J. Immunol. 166, 3589-3598
 |  Abstract »  |  Full Text »  |  PDF »

Antibodies Elicited by Naked DNA Vaccination against the Complementary-determining Region 3 Hypervariable Region of Immunoglobulin Heavy Chain Idiotypic Determinants of B-lymphoproliferative Disorders Specifically React with Patients' Tumor Cells.

M. Rinaldi, F. Ria, P. Parrella, E. Signori, A. Serra, S. A. Ciafrè, I. Vespignani, M. Lazzari, M. G. Farace, G. Saglio, et al. (2001)
Cancer Res. 61, 1555-1562
 |  Abstract »  |  Full Text »

Vaccination with Allergen-IL-18 Fusion DNA Protects Against, and Reverses Established, Airway Hyperreactivity in a Murine Asthma Model.

H. T. Maecker, G. Hansen, D. M. Walter, R. H. DeKruyff, S. Levy, and D. T. Umetsu (2001)
J. Immunol. 166, 959-965
 |  Abstract »  |  Full Text »  |  PDF »

Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer.

S. Zucchelli, S. Capone, E. Fattori, A. Folgori, A. Di Marco, D. Casimiro, A. J. Simon, R. Laufer, N. La Monica, R. Cortese, et al. (2000)
J. Virol. 74, 11598-11607
 |  Abstract »  |  Full Text »

Protection of Macaca nemestrina from Disease following Pathogenic Simian Immunodeficiency Virus (SIV) Challenge: Utilization of SIV Nucleocapsid Mutant DNA Vaccines with and without an SIV Protein Boost.

R. J. Gorelick, R. E. Benveniste, J. D. Lifson, J. L. Yovandich, W. R. Morton, L. Kuller, B. M. Flynn, B. A. Fisher, J. L. Rossio, M. Piatak Jr., et al. (2000)
J. Virol. 74, 11935-11949
 |  Abstract »  |  Full Text »

DNA vaccination: antigen presentation and the induction of immunity.

D. J. Shedlock and D. B. Weiner (2000)
J. Leukoc. Biol. 68, 793-806
 |  Abstract »  |  Full Text »

Preventive Effect of Local Plasmid DNA Vaccine Encoding gD or gD-IL-2 on Herpetic Keratitis.

T. Inoue, Y. Inoue, T. Nakamura, A. Yoshida, K. Takahashi, Y. Inoue, Y. Shimomura, Y. Tano, Y. Fujisawa, A. Aono, et al. (2000)
Invest. Ophthalmol. Vis. Sci. 41, 4209-4215
 |  Abstract »  |  Full Text »

A Targeted DNA Vaccine Augments the Natural Immune Response to Self TNF-{alpha} and Suppresses Ongoing Adjuvant Arthritis.

G. Wildbaum, S. Youssef, and N. Karin (2000)
J. Immunol. 165, 5860-5866
 |  Abstract »  |  Full Text »  |  PDF »

Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination.

D. H. Barouch, S. Santra, J. E. Schmitz, M. J. Kuroda, T.-M. Fu, W. Wagner, M. Bilska, A. Craiu, X. X. Zheng, G. R. Krivulka, et al. (2000)
Science 290, 486-492
 |  Abstract »  |  Full Text »

Prevention of Adult T-Cell Leukemia-Like Lymphoproliferative Disease in Rats by Adoptively Transferred T Cells from a Donor Immunized with Human T-Cell Leukemia Virus Type 1 Tax-Coding DNA Vaccine.

T. Ohashi, S. Hanabuchi, H. Kato, H. Tateno, F. Takemura, T. Tsukahara, Y. Koya, A. Hasegawa, T. Masuda, and M. Kannagi (2000)
J. Virol. 74, 9610-9616
 |  Abstract »  |  Full Text »

Induction of Vigorous Helper and Cytotoxic T Cell as well as B Cell Responses by Dendritic Cells Expressing a Modified Antigen Targeting Receptor-Mediated Internalization Pathway.

Z. You, X. F. Huang, J. Hester, L. Rollins, C. Rooney, and S.-Y. Chen (2000)
J. Immunol. 165, 4581-4591
 |  Abstract »  |  Full Text »  |  PDF »

Genetic Vaccination against Malaria Infection by Intradermal and Epidermal Injections of a Plasmid Containing the Gene Encoding the Plasmodium berghei Circumsporozoite Protein.

R. Weiss, W. W. Leitner, S. Scheiblhofer, D. Chen, A. Bernhaupt, S. Mostbock, J. Thalhamer, and J. A. Lyon (2000)
Infect. Immun. 68, 5914-5919
 |  Abstract »  |  Full Text »  |  PDF »

Direct Ex Vivo Kinetic and Phenotypic Analyses of CD8+ T-Cell Responses Induced by DNA Immunization.

D. E. Hassett, M. K. Slifka, J. Zhang, and J. L. Whitton (2000)
J. Virol. 74, 8286-8291
 |  Abstract »  |  Full Text »

DNA Vaccines for Influenza Virus: Differential Effects of Maternal Antibody on Immune Responses to Hemagglutinin and Nucleoprotein.

T. M. Pertmer, A. E. Oran, J. M. Moser, C. A. Madorin, and H. L. Robinson (2000)
J. Virol. 74, 7787-7793
 |  Abstract »  |  Full Text »

Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice.

M. Dupuis, K. Denis-Mize, C. Woo, C. Goldbeck, M. J. Selby, M. Chen, G. R. Otten, J. B. Ulmer, J. J. Donnelly, G. Ott, et al. (2000)
J. Immunol. 165, 2850-2858
 |  Abstract »  |  Full Text »  |  PDF »

Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates.

J. M. Heile, Y.-L. Fong, D. Rosa, K. Berger, G. Saletti, S. Campagnoli, G. Bensi, S. Capo, S. Coates, K. Crawford, et al. (2000)
J. Virol. 74, 6885-6892
 |  Abstract »  |  Full Text »

Enhancement of Primary and Secondary Cellular Immune Responses against Human Immunodeficiency Virus Type 1 Gag by Using DNA Expression Vectors That Target Gag Antigen to the Secretory Pathway.

J.-T. Qiu, B. Liu, C. Tian, G. N. Pavlakis, and X.-F. Yu (2000)
J. Virol. 74, 5997-6005
 |  Abstract »  |  Full Text »

Human herpesviruses in the cornea.

S. B Kaye, K. Baker, R. Bonshek, H. Maseruka, E. Grinfeld, A. Tullo, D. L Easty, and C. A Hart (2000)
Br J Ophthalmol 84, 563-571
 |  Abstract »  |  Full Text »

Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen.

T. M. Allen, T. U. Vogel, D. H. Fuller, B. R. Mothe, S. Steffen, J. E. Boyson, T. Shipley, J. Fuller, T. Hanke, A. Sette, et al. (2000)
J. Immunol. 164, 4968-4978
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products